Prevalence, views and experience of e-cigarette use by COPD patients in The Birmingham COPD Cohort

M. Swallow (Birmingham, United Kingdom), A. Farley (Birmingham, United Kingdom), R. Jordan (Birmingham, United Kingdom), A. Enocson (Birmingham, United Kingdom), A. Dickens (Birmingham, United Kingdom), D. Fitzmaurice (Coventry, United Kingdom), P. Adab (Birmingham, United Kingdom)

Source: International Congress 2018 – Epidemiology of the use of traditional and emerging tobacco products and e-cigarettes
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Swallow (Birmingham, United Kingdom), A. Farley (Birmingham, United Kingdom), R. Jordan (Birmingham, United Kingdom), A. Enocson (Birmingham, United Kingdom), A. Dickens (Birmingham, United Kingdom), D. Fitzmaurice (Coventry, United Kingdom), P. Adab (Birmingham, United Kingdom). Prevalence, views and experience of e-cigarette use by COPD patients in The Birmingham COPD Cohort. 4547

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence and predictors of electronic cigarette use by patients with COPD in the Birmingham COPD cohort
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016

Comparison of characteristics of COPD patients with an established diagnosis, with those newly identified through case-finding – The Birmingham COPD cohort study
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014


Do depression and living alone decrease the likelihood of smoking cessation in patients admitted with exacerbations of COPD? A retrospective audit
Source: International Congress 2014 – Smoking cessation
Year: 2014

Effect of COPD medications on exacerbation rates in a real-life COPD patient cohort - data from the Czech Multicenter Research Database of COPD.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Experience of work with patients with COPD
Source: Annual Congress 2013 –Improving educational programmes for patients and multidisciplinary healthcare professionals
Year: 2013

The effects of disease progression on work productivity: the Birmingham COPD Cohort
Source: International Congress 2019 – Airway and parenchymal diseases in occupational and environmental lung diseases
Year: 2019

The prevalence of symptoms suggestive of COPD amongst patients attending an illicit drug misuse clinic
Source: Annual Congress 2013 –COPD and tobacco management
Year: 2013

Birmingham COPD cohort: Comparison of characteristics of employed with non-employed patients
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013


Statin use and risk of exacerbations in individuals with COPD: The Copenhagen general population study
Source: International Congress 2014 – New insights into the epidemiology of COPD
Year: 2014

Flying with COPD; a survey of patients‘ experiences
Source: Eur Respir J 2003; 22: Suppl. 45, 553s
Year: 2003

Patterns in patient experience of COPD exacerbations in the UK, Denmark and Netherlands - a qualitative study
Source: Eur Respir J 2003; 22: Suppl. 45, 67s
Year: 2003

Risk factors associated to COPD worsening in Italian general practices: The 12 month COMODHES follow-up study
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

Prevalence of COPD in heroin smokers screened at substance misuse clinics
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016

Prevalence and incidence of COPD: The Rotterdam study
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015


Factors associated with COPD exacerbation frequency in a UK primary care cohort
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013

Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET
Source: ERJ Open Res, 7 (3) 00242-2021; 10.1183/23120541.00242-2021
Year: 2021



Use of medicines and prevalence of co-morbid diseases in subjects with and without COPD in Sweden
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013

Dual bronchodilation in real-life COPD management: analysis of patients’ characteristics enrolled in COPD Registry in Russia
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Multi-centre research: The experience of a UK, Danish and Dutch qualitative study exploring the meaning of COPD and its exacerbations to patients
Source: Eur Respir J 2003; 22: Suppl. 45, 66s
Year: 2003

Investigation of the prevalence of comorbidities in patients with COPD using the Italian college of general practitioners (SIMG) database
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009